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SUMMARY OF THESIS*
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2001. (Dissertação de Mestrado - Faculdade de Saúde Pública da Universidade de São Paulo).
EVALUATION OF THE RESPONSE TO VACCINATION AGAINST MEASLES
IN BONE MARROW TRANSPLANT RECIPIENTS
To evaluate the extinction of specific antibodies and the response to
vaccination against measles in bone marrow transplant (BMT) recipients,
43 patients were studied: 23 patients vaccinated two years after
transplantation (group1 or late vaccination group) and 20 patients
vaccinated one year after BMT (group 2 or early vaccination group).
The prevalence of measles IgG antibodies was evaluated by Enzyme
Immunosorbet Assay (E.I.A). Antibody avidity, expressed by the mean
avidity index, was determined by the urea method.
All patients had measles antibodies titers higher than 100 mUI/ml at
the moment of transplant. A progressive decrease in antibody titer was
observed during follow-up. Sixteen patients (69.6%) in group 1 and 4
(20.0%) in group 2 were susceptible to measles at the time of vaccination.
The overall response rate was 81.3% and statistically similar in both
groups: 91.3% of the patients in group 1 (21/23) and 75.0% in group 2
(15/20). The mean antibody titers after vaccination were comparable in
both groups, 885 mUI/ml in group 1 and 941 mUI/ml in group 2.
Among the 20 patients susceptible to measles at the time of
vaccination, 6 presented low avidity antibodies on post vaccination
sample, indicative of primary immune response. In the remaining 10
who were seronegative at vaccination, as well as in the 23 patients who
were seropositive at the time of vaccine administration, medium and
high avidity antibodies were detected, indicating a secondary immune
response. No side effects to measles vaccine were reported.
Four patients, all from group 1, lost measles immunity one to two
years after vaccination.
The results of the present study suggest persistence of donor memory
B cells. Early vaccination against measles can be strategically
recommended specially in some circumstances such as outbreaks, when
the risk of measles infection is high in this population. Alternative
schedules or additional doses of measles vaccine should be better
investigated in this setting.
